Skip to main content

Table 3 Post anaesthesia care unit characteristics

From: Sugammadex, neostigmine and postoperative pulmonary complications: an international randomised feasibility and pilot trial

Characteristic

Sugammadex (n = 59)

Neostigmine (n = 61)

PACU

 Direct ICU/HDU transfer

2 (3.4)

1 (1.6)

 Airway management in PACU

0

0

 Duration of PACU stay (h)

1.2 (0.8–2.0)

1.1 (0.7–1.6)

Discharge destination from PACU

 Ward

50 (87.7)

54 (90.0)

 ICU/HDU

7 (12.3)

6 (10.0)

Acceptability of protocol

 Highly acceptable

32 (56.1)

25 (42.4)

 Acceptable

24 (42.1)

27 (45.8)

 Neutral

0 (0.0)

3 (5.1)

 Unacceptable

1 (1.8)

3 (5.1)

 Highly unacceptable

0 (0.0)

1 (1.7)

Postoperative day 1

 PONV since PACU arrival

26 (44.1)

30 (49.2)

 Anti-emetic since PACU arrival

25 (42.4)

34 (55.7)

 QoR-15

101.2 (18.0)

102.6 (14.5)

 Change in QoR-15 (day 1 - preoperative)

−30.3 (21.0)

−34.3 (18.3)

 EQ-5D-5L score

0.4 (0.1–0.6)

0.4 (0.1–0.5)

 EQ-VAS score

60.0 (50.0–80.0)

70.0 (60.0–75.0)

Hospital discharge

 Unplanned ICU/HDU admission

3 (5.1)

2 (3.3)

 Duration of hospital stay (days)

5.1 (3.1–9.2)

5.1 (3.2–8.2)

 Primary outcome—adjudicated

5 (8.5)

5 (8.2)

 Atelectasis

5 (8.5)

5 (8.2)

Postoperative day 30

 Days alive and at home

25.0 (19.0–27.0)

24.0 (21.0–27.0)

Postoperative 3 months

 EQ-5D-5L score

0.9 (0.8–1.0)

0.9 (0.8–1.0)

 EQ-VAS score

80.0 (65.0–86.0)

80.0 (70.0–90.0)

Frailty

 Non-frail (CFS score = 1–4)

55 (94.8)

56 (96.6)

 Frail (CFS score = 5–9)

3 (5.2)

2 (3.4)

  1. Results are presented as mean (standard deviation), median (interquartile range), and number (percent). CFS Clinical Frailty Scale, EQ-5D-5L EuroQol 5-dimension 5-level, EQ-VAS EuroQol–Visual Analogue Scale, HDU high dependency unit, ICU intensive care unit, PACU post-anaesthesia care unit, QoR quality of recovery. Missing data: duration of PACU stay = 3 (2.5%), discharge destination from PACU = 3 (2.5%) (these patients admitted directly to ICU); acceptability of protocol = 4 (3.3%), CFS = 4 (3.3%); postoperative 3 months EQ-5D-5L/EQ-VAS = 4 (3.3%)